SueWallSt Issues Alert on Park Ha Biological Technology Class Action Deadlines for BYAH Investors

SueWallSt Issues Alert on Park Ha Biological Technology Class Action Deadlines for BYAH Investors



In a significant legal development, SueWallSt has issued a reminder to investors of Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) regarding a securities class action that has been filed against the company. The deadline for impacted investors to act is fast approaching—September 28, 2026. This case stems from allegations that the company's December 2024 registration statement failed to disclose critical information regarding its public float, which some claim facilitated a fraudulent scheme.

Background on the Allegations



The class action centers around Sections 11 and 12 of the Securities Act, which raise concerns over potential misstatements in Park Ha's registration documents. Specifically, a significant issue arose when it was noted that only 1,200,000 out of 26,200,000 total ordinary shares were made available to the public during the initial offering. This reportedly left a public float of less than 5%. Plaintiffs argue that this structure was intentionally designed to allow for manipulation, contributing to a dramatic market volatility that saw shares plummet.

Investors who purchased BYAH shares between December 27, 2024, and July 8, 2025, and subsequently suffered a loss, may be eligible to join this class action. The stock's history is illuminating; following its IPO at $4.00 per share, it reached a staggering $41.49 on July 7, 2025, only to close at $2.99 a day later—a staggering drop of 93%.

Legal Context and Deadlines



The lawsuit, which is pending in the United States District Court for the Southern District of New York, raises serious claims under key provisions of the Securities Act and Exchange Act. Investors intending to file as lead plaintiffs must submit their motions by the looming deadline of September 28, 2026. Those who opt not to serve as lead plaintiffs—typically chosen from among those with the largest documented financial losses—can still participate in any recovery without additional submission.

Joseph E. Levi, Esq., the attorney representing the plaintiffs, emphasized, "The Private Securities Litigation Reform Act offers crucial protections for investors wronged by alleged violations in securities laws. This class action focuses on what was, and wasn’t, disclosed in relation to the public float." This highlights the idea that though a company may present its offerings legally, the nuances of disclosure are what make or break investor trust.

Important Points for BYAH Investors



1. Eligibility: Investors who bought shares during the specified timeframe and incurred losses are encouraged to submit their information promptly to determine their eligibility status.
2. No Cost to Participate: Potential participants need not worry about upfront costs, as securities class actions typically operate on a contingency basis, ensuring that investors won’t bear immediate costs when seeking justice.
3. International Considerations: For investors outside the U.S., it is noted that class action laws may cover stock purchases made on U.S. exchanges, regardless of the investor's location.

How to Proceed



Those who believe they have been impacted by this situation are advised to gather necessary documentation, including brokerage statements that detail purchase dates, share quantities, and any subsequent sale information. Interested parties can reach out to Joseph E. Levi, Esq. at [email protected] or contact the law firm at (888) SueWallSt.

This situation serves as a reminder of the complex nature of securities trading and the necessity for complete transparency in offerings. With the class action date fast approaching, impacted investors should take immediate action to secure their potential claims in this case.

Conclusion



The narrative surrounding Park Ha Biological Technology Co. illustrates the pivotal role of corporate management in ensuring that all aspects of investment risks are adequately communicated to shareholders. As the September deadline looms, vigilance is vital for investors hoping to navigate this class action landscape successfully.

Topics Financial Services & Investing)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.